Pittsburgh

Moderna files for emergency use authorization for its COVID-19 vaccine for ages 12 to 17 – Pittsburgh, Pennsylvania

Pittsburgh, Pennsylvania 2021-06-10 10:27:00 –

Video above: Moderna is working on COVID-19 vaccination for children up to the age of 5 by early fall. Moderna has applied for an emergency use authorization with the Food and Drug Administration for the COVID-19 vaccine for people aged 12 to 17 years. The Moderna vaccine is currently approved for people over the age of 18. Last month, Moderna announced the results of a Phase 2/3 trial in the United States of 3,732 children aged 12 to 17 years. Blood tests have shown that the vaccine produces an immune response comparable to previous findings in adults. In that study, the first observations showed that none of the vaccinated children became ill with COVID-19 14 days after the second dose. Four of the children who received the placebo tested positive for COVID-19. The company has already applied for youth vaccine approval from Canadian and European regulators. Pfizer approved the use of the coronavirus vaccine on May 10 for people up to the age of 12. Another COVID-19 vaccine available in the United States, manufactured by Johnson & Johnson and also known as the Janssen vaccine, is currently licensed for people over the age of 18.

Video above: Moderna working to vaccinate children up to 5 years old with COVID-19 vaccine by early fall

According to the company’s news release, Moderna has applied for an emergency use authorization from the Food and Drug Administration for the COVID-19 vaccine for people between the ages of 12 and 17.

The Moderna vaccine is currently approved for people over the age of 18.

last month, Moderna announces results From a Phase 2/3 trial of 3,732 children aged 12 to 17 in the United States. Blood tests have shown that the vaccine produces an immune response comparable to previous findings in adults. In that study, the first observations showed that none of the vaccinated children became ill with COVID-19 14 days after the second dose. Four children who received placebo were COVID-19 positive.

The company has already applied for youth vaccine approval from Canadian and European regulators.

Pfizer was licensed on May 10 for a 12-year-old youth to use the coronavirus vaccine.

Another COVID-19 vaccine available in the United States, manufactured by Johnson & Johnson and also known as the Janssen vaccine, is currently licensed for people over the age of 18.

Moderna files for emergency use authorization for its COVID-19 vaccine for ages 12 to 17 Source link Moderna files for emergency use authorization for its COVID-19 vaccine for ages 12 to 17

Back to top button